Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Curaleaf Holdings's share price for the quarter that ended in Mar. 2026 was C$9. Curaleaf Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 260 Mil. Therefore, Curaleaf Holdings's market cap for the quarter that ended in Mar. 2026 was C$2,344 Mil.
Curaleaf Holdings's quarterly market cap
declined
from Sep. 2025 (C$2,935 Mil) to Dec. 2025 (C$2,634 Mil) and
declined
from Dec. 2025 (C$2,634 Mil) to Mar. 2026 (C$2,344 Mil).
Curaleaf Holdings's annual market cap
declined
from Dec. 2023 (C$4,043 Mil) to Dec. 2024 (C$1,680 Mil) but then
increased
from Dec. 2024 (C$1,680 Mil) to Dec. 2025 (C$2,634 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Curaleaf Holdings's Enterprise Value for Today is C$4,672 Mil.
Curaleaf Holdings (TSX:CURA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Curaleaf Holdings Market Cap Related Terms
Curaleaf Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Curaleaf Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curaleaf Holdings Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Curaleaf Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Curaleaf Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curaleaf Holdings (TSX:CURA) has a Market Cap of C$3,520 Mil as of Jul. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Curaleaf Holdings and its competitors. According to the industry distribution chart, Curaleaf Holdings ranks #128 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 12.5%.
Is Curaleaf Holdings' Market Cap too high?
Curaleaf Holdings' current Market Cap is C$3,520 Mil. Based on the distribution chart, Curaleaf Holdings ranks #128 out of 1024 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Curaleaf Holdings has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curaleaf Holdings ranks #128 out of 1024 companies for Market Cap. This places Curaleaf Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median Market Cap is 214.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 214.89, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Curaleaf Holdings and its competitors. For the Drug Manufacturers industry, the median Market Cap is 214.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curaleaf Holdings's current Market Cap is C$3,520 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (TSX:CURA) is currently considered Modestly Overvalued. The stock's GF Value™ is C$11.39, compared to a current price of C$13.32 — trading 16.9% above its estimated fair value. The current Market Cap is C$3,520 Mil. Curaleaf Holdings' overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Curaleaf Holdings (TSX:CURA), the current Market Cap is C$3,520 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Curaleaf Holdings (TSX:CURA) Overvalued in 2026?
Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued.
The current stock price of C$13.32 is trading 16.9% above its estimated GF Value™ of C$11.39.
GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.
Key valuation signals for TSX:CURA:
Market Cap: C$3,520 Mil
GF Value™: C$11.39 vs. price of C$13.32 (16.9% above fair value)
No single metric tells the full story. See the TSX:CURA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
76GF Score
Get the complete analysis for TSX:CURA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:CURA has been successfully added to your 
